← Home / Vanda Pharmaceuticals Inc. (VNDA)
Stock Analysis
Vanda Pharmaceuticals Inc. (VNDA)
VNDA
VNDA · Market data
5.96 +4.01%
52W Range Position
33%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-06-18 13:41 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
Fundamentals
Moderate / Negative
Price Structure
Vulnerable
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
Break Above
Confirmation improves above resistance.
6.39
🎯
Next Objective
Pattern-derived target if setup continues.
7.92
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving VNDA?
📈 Technical recovery is improving
Momentum is Neutral. Watch 6.39 for confirmation and for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Full Analysis Workspace
Technical Signal
Technical Setup Active
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Triangle Compression / SYM / UP
State
Active
Trigger
5.79
Target
7.92
Risk / Invalid
5.29
Breakout Watch
Downtrend line not broken yet · score 26
Watch Level
6.14
Compression
71%
How to read this setup
Active technical structure detected. Use the chart overlays, support, resistance and invalidation levels to manage confirmation and risk.
Price Chart
VNDA · WOI overlay chart
Open Full Workspace
Business Lens
Financial pressure is elevated
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
Revenue Growth
Moderate
Profitability
Negative
Cash Flow
Pressured
Balance Sheet
Manageable
💵 Revenue
51.72M
≈ Moderate
📈 Net Income
-48.57M
↘ Negative
🧮 EPS (Basic)
-0.82
↘ Negative
Vanda Pharmaceuticals Inc.
Note: This is an algorithmic technical snapshot, not financial advice.